bpc-157 adverse event case report human Risks for Musculoskeletal Injuries GLP-1 medications and peptide therapies

This area is often chosen because it provides a large, well-developed muscle that can accommodate the injection without causing discomfort

BPC-157 peptide therapy is a treatment that uses a synthetic peptide called Body Protection Compound-157 (BPC-157)

People of thiamin deficiency include those affected by: pregnancy chronic illness inadequate dietary intake alcoholism bariatric surgery chronic diuretic therapy Prolonged, untreated thiamin deficiency may lead to Wernicke-Korsakoff syndrome, a disorder that can affect people with chronic alcoholism, gastrointestinal disorders, or AIDS

At the same time, long-term safety in larger and more diverse human populations has not been conclusively established, so the responsible position sits between calling it simply safe or unsafe